These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30732469)

  • 1. Explanation of Postprocedural Fractional Flow Reserve Below 0.85.
    van Zandvoort LJC; Masdjedi K; Witberg K; Ligthart J; Tovar Forero MN; Diletti R; Lemmert ME; Wilschut J; de Jaegere PPT; Boersma E; Zijlstra F; Van Mieghem NM; Daemen J
    Circ Cardiovasc Interv; 2019 Feb; 12(2):e007030. PubMed ID: 30732469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine Fractional Flow Reserve Measurement After Percutaneous Coronary Intervention.
    van Bommel RJ; Masdjedi K; Diletti R; Lemmert ME; van Zandvoort L; Wilschut J; Zijlstra F; de Jaegere P; Daemen J; van Mieghem NM
    Circ Cardiovasc Interv; 2019 May; 12(5):e007428. PubMed ID: 31018666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of post-stenting fractional flow reserve with intravascular ultrasound parameters for optimal stent deployment.
    Ahn SG; Hong S; Son JW; Lee JW; Youn YJ; Ahn MS; Kim JY; Yoo BS; Lee SH; Yoon J
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):197-203. PubMed ID: 31659602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
    Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Segmental Post-PCI Physiological Gradients With IVUS-Detected Focal Lesions and Stent Underexpansion.
    Neleman T; Scoccia A; Groenland FTW; Ziedses des Plantes AC; van Zandvoort LJC; Ligthart JMR; Witberg KT; Lenzen MJ; Boersma E; Nuis RJ; den Dekker WK; Diletti R; Wilschut J; Zijlstra F; Van Mieghem NM; Daemen J
    JACC Cardiovasc Interv; 2023 Jul; 16(14):1763-1773. PubMed ID: 37354158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Implications of Post-Intervention Resting Pd/Pa and Fractional Flow Reserve in Patients With Stent Implantation.
    Shin D; Lee SH; Lee JM; Choi KH; Hwang D; Lee HJ; Jang HJ; Kim HK; Kwak JJ; Ha SJ; Song YB; Shin ES; Doh JH
    JACC Cardiovasc Interv; 2020 Aug; 13(16):1920-1933. PubMed ID: 32819481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention.
    Uretsky BF; Agarwal SK; Vallurupalli S; Al-Hawwas M; Hasan R; Miller K; Hakeem A
    J Am Heart Assoc; 2020 Feb; 9(3):e015073. PubMed ID: 32013707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic impact of changes in bifurcation geometry after single-stent cross-over technique assessed by intravascular ultrasound and fractional flow reserve.
    Kang SJ; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1075-82. PubMed ID: 23592548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study.
    Li SJ; Ge Z; Kan J; Zhang JJ; Ye F; Kwan TW; Santoso T; Yang S; Sheiban I; Qian XS; Tian NL; Rab TS; Tao L; Chen SL
    JACC Cardiovasc Interv; 2017 May; 10(10):986-995. PubMed ID: 28456699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.
    Agostoni P; Belkacemi A; Voskuil M; Nathoe HM; Doevendans PA; Stella PR
    JACC Cardiovasc Interv; 2013 Jun; 6(6):569-76. PubMed ID: 23683736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR-OCT co-registration study.
    Pyxaras SA; Adriaenssens T; Barbato E; Ughi GJ; Di Serafino L; De Vroey F; Toth G; Tu S; Reiber JHC; Bax JJ; Wijns W
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):495-502. PubMed ID: 29080150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Implications of Relative Increase and Final Fractional Flow Reserve in Patients With Stent Implantation.
    Lee JM; Hwang D; Choi KH; Rhee TM; Park J; Kim HY; Jung HW; Hwang JW; Lee HJ; Jang HJ; Kim SH; Song YB; Cho YK; Nam CW; Hahn JY; Shin ES; Kawase Y; Matsuo A; Tanaka N; Doh JH; Koo BK; Matsuo H
    JACC Cardiovasc Interv; 2018 Oct; 11(20):2099-2109. PubMed ID: 30336814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of microvascular resistance on fractional flow reserve after successful percutaneous coronary intervention.
    Murai T; Lee T; Yonetsu T; Isobe M; Kakuta T
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):585-92. PubMed ID: 24678006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the trans-stent fractional flow reserve gradient for predicting clinical outcomes.
    Yang HM; Lim HS; Yoon MH; Seo KW; Choi BJ; Choi SY; Hwang GS; Tahk SJ
    Catheter Cardiovasc Interv; 2020 Apr; 95(5):E123-E129. PubMed ID: 31169345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes.
    Agarwal SK; Kasula S; Hacioglu Y; Ahmed Z; Uretsky BF; Hakeem A
    JACC Cardiovasc Interv; 2016 May; 9(10):1022-31. PubMed ID: 27198682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of insufficient improvement in fractional flow reserve following percutaneous coronary intervention.
    Hirai K; Kawasaki T; Sakakura K; Soejima T; Kajiyama K; Fukami Y; Haraguchi K; Okonogi T; Fukuoka R; Orita Y; Umeji K; Koga H; Yamabe H
    Heart Vessels; 2020 Dec; 35(12):1650-1656. PubMed ID: 32524237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preintervention angiographic and intravascular ultrasound predictors for side branch compromise after a single-stent crossover technique.
    Kang SJ; Mintz GS; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Am J Cardiol; 2011 Jun; 107(12):1787-93. PubMed ID: 21507367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Residual Anatomic Disease Burden After Functionally Complete Revascularization.
    Lee JM; Hwang D; Choi KH; Lee HJ; Song YB; Cho YK; Nam CW; Hahn JY; Shin ES; Doh JH; Hoshino M; Hamaya R; Kanaji Y; Murai T; Zhang JJ; Ye F; Li X; Ge Z; Chen SL; Kakuta T; Koo BK
    Circ Cardiovasc Interv; 2020 Sep; 13(9):e009232. PubMed ID: 32895005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline fractional flow reserve and stent diameter predict optimal post-stent fractional flow reserve and major adverse cardiac events after bare-metal stent deployment.
    Samady H; McDaniel M; Veledar E; De Bruyne B; Pijls NH; Fearon WF; Vaccarino V
    JACC Cardiovasc Interv; 2009 Apr; 2(4):357-63. PubMed ID: 19463450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.